The Centers for Disease Control and Prevention continues to recommend early treatment with antiviral medications for hospitalized patients and high-risk outpatients with flu, including children under 2 years old, the agency said Friday in an advisory. Clinicians also should vaccinate patients for as long as flu viruses are circulating, and promptly start antiviral treatment for severely ill and high-risk patients with suspected flu without waiting for laboratory confirmation, the agency said. Outpatient visits for flu-like illness have been elevated for nine weeks, primarily due to certain influenza B viruses that can cause severe illness in all ages and higher pediatric mortality. Certain influenza A viruses that can cause severe illness also are increasing, CDC said.

Related News Articles

Headline
Adam Myers, M.D., population health chief at Cleveland Clinic, talks with Nancy Foster, AHA vice president for quality and patient safety, about preventing flu…
Headline
The Food and Drug Administration yesterday released an updated template for developers requesting emergency use authorization for antigen tests for…
Headline
To continue amplifying the important message of protecting against both the flu and COVID-19, AHA’s United Against the Flu campaign today released new…
Headline
In this AHA podcast, Rita Carreon, deputy vice president for health, UnidosUS, and Elisa Arespacochaga, vice president of the AHA’s Physician Alliance, discuss…
Headline
The American Medical Association today released for immediate use Current Procedural Terminology codes for reporting on medical claims two laboratory tests (…
Headline
A new Centers for Disease Control and Prevention study suggests that social distancing and other measures to stop the spread of SARS-CoV-2 could help reduce…